Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions
Clinical trial NCT00659074 · COMPLETED
Trial details
- NCT number
- NCT00659074
- Sponsor
- Par Pharmaceutical, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2004-01-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.